341 related articles for article (PubMed ID: 34726531)
1. Radiomics for Survival Risk Stratification of Clinical and Pathologic Stage IA Pure-Solid Non-Small Cell Lung Cancer.
Wang T; She Y; Yang Y; Liu X; Chen S; Zhong Y; Deng J; Zhao M; Sun X; Xie D; Chen C
Radiology; 2022 Feb; 302(2):425-434. PubMed ID: 34726531
[TBL] [Abstract][Full Text] [Related]
2. Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer.
Huang Y; Liu Z; He L; Chen X; Pan D; Ma Z; Liang C; Tian J; Liang C
Radiology; 2016 Dec; 281(3):947-957. PubMed ID: 27347764
[TBL] [Abstract][Full Text] [Related]
3. Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: Role of Preoperative CT Features in Predicting Pathologic Lymphovascular Invasion and Postoperative Recurrence.
Choe J; Kim MY; Yun JK; Lee GD; Kim YH; Choi S; Kim DK
AJR Am J Roentgenol; 2021 Oct; 217(4):871-881. PubMed ID: 33978462
[No Abstract] [Full Text] [Related]
4. Radiomics Signature Predicts the Recurrence-Free Survival in Stage I Non-Small Cell Lung Cancer.
Wang T; Deng J; She Y; Zhang L; Wang B; Ren Y; Wu J; Xie D; Sun X; Chen C
Ann Thorac Surg; 2020 Jun; 109(6):1741-1749. PubMed ID: 32087134
[TBL] [Abstract][Full Text] [Related]
5. Deep Learning for Prediction of N2 Metastasis and Survival for Clinical Stage I Non-Small Cell Lung Cancer.
Zhong Y; She Y; Deng J; Chen S; Wang T; Yang M; Ma M; Song Y; Qi H; Wang Y; Shi J; Wu C; Xie D; Chen C;
Radiology; 2022 Jan; 302(1):200-211. PubMed ID: 34698568
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of a small component of ground-glass opacity in solid-dominant clinical stage IA non-small cell lung cancer.
Watanabe Y; Hattori A; Nojiri S; Matsunaga T; Takamochi K; Oh S; Suzuki K
J Thorac Cardiovasc Surg; 2022 Mar; 163(3):791-801.e4. PubMed ID: 33516459
[TBL] [Abstract][Full Text] [Related]
7. A Radiomics Signature in Preoperative Predicting Degree of Tumor Differentiation in Patients with Non-small Cell Lung Cancer.
Chen X; Fang M; Dong D; Wei X; Liu L; Xu X; Jiang X; Tian J; Liu Z
Acad Radiol; 2018 Dec; 25(12):1548-1555. PubMed ID: 29572049
[TBL] [Abstract][Full Text] [Related]
8. Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study.
Hosny A; Parmar C; Coroller TP; Grossmann P; Zeleznik R; Kumar A; Bussink J; Gillies RJ; Mak RH; Aerts HJWL
PLoS Med; 2018 Nov; 15(11):e1002711. PubMed ID: 30500819
[TBL] [Abstract][Full Text] [Related]
9. Elaboration of a multimodal MRI-based radiomics signature for the preoperative prediction of the histological subtype in patients with non-small-cell lung cancer.
Tang X; Xu X; Han Z; Bai G; Wang H; Liu Y; Du P; Liang Z; Zhang J; Lu H; Yin H
Biomed Eng Online; 2020 Jan; 19(1):5. PubMed ID: 31964407
[TBL] [Abstract][Full Text] [Related]
10. Simple preoperative computed tomography image analysis shows good predictive performance for pathological vessel invasion in clinical stage IA non-small cell lung cancer.
Ito T; Murakawa T; Sato H; Tanabe A; Maekawa M; Yoshida Y; Fukayama M; Nakajima J
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):633-8. PubMed ID: 22740516
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Li B; Cui Y; Diehn M; Li R
JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
[TBL] [Abstract][Full Text] [Related]
12. Development of a predictive radiomics model for lymph node metastases in pre-surgical CT-based stage IA non-small cell lung cancer.
Cong M; Feng H; Ren JL; Xu Q; Cong L; Hou Z; Wang YY; Shi G
Lung Cancer; 2020 Jan; 139():73-79. PubMed ID: 31743889
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Impact of Tumor Volume in Patients with Clinical Stage IA Non-Small Cell Lung Cancer.
Takenaka T; Yamazaki K; Miura N; Mori R; Takeo S
J Thorac Oncol; 2016 Jul; 11(7):1074-80. PubMed ID: 26899756
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of segmentectomy versus lobectomy for radiologically pure solid or solid-dominant stage IA non-small cell lung cancer.
Rao S; Ye L; Min L; Zhao G; Chen Y; Huang Y; Yang J; Xiao S; Cao R
J Cardiothorac Surg; 2019 Nov; 14(1):197. PubMed ID: 31722726
[TBL] [Abstract][Full Text] [Related]
15. Radiomics nomogram integrating intratumoural and peritumoural features to predict lymph node metastasis and prognosis in clinical stage IA non-small cell lung cancer: a two-centre study.
Chen QL; Li MM; Xue T; Peng H; Shi J; Li YY; Duan SF; Feng F
Clin Radiol; 2023 May; 78(5):e359-e367. PubMed ID: 36858926
[TBL] [Abstract][Full Text] [Related]
16. Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC.
Dou TH; Coroller TP; van Griethuysen JJM; Mak RH; Aerts HJWL
PLoS One; 2018; 13(11):e0206108. PubMed ID: 30388114
[TBL] [Abstract][Full Text] [Related]
17. Clinical Utility of a CT-based AI Prognostic Model for Segmentectomy in Non-Small Cell Lung Cancer.
Na KJ; Kim YT; Goo JM; Kim H
Radiology; 2024 Apr; 311(1):e231793. PubMed ID: 38625008
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer.
Yu W; Tang C; Hobbs BP; Li X; Koay EJ; Wistuba II; Sepesi B; Behrens C; Rodriguez Canales J; Parra Cuentas ER; Erasmus JJ; Court LE; Chang JY
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1090-1097. PubMed ID: 29246722
[TBL] [Abstract][Full Text] [Related]
19. Cone-beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients.
Qin Q; Shi A; Zhang R; Wen Q; Niu T; Chen J; Qiu Q; Wan Y; Sun X; Xing L
Thorac Cancer; 2020 Apr; 11(4):964-972. PubMed ID: 32061061
[TBL] [Abstract][Full Text] [Related]
20. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
